<P>&nbsp;</P> <P align=justify>Supported by Lyonbiop&#244;le, the world competitiveness cluster specialized in the fight against infectious diseases and cancers, <STRONG><STRONG><A title="" href="https://www.aderly.com/lyon-economic-news/biotechnologie-france-europe-news-ACCINOV-COMES-TO-LYON-AND-RECEIVE-THE-HELP-OF-ADERLY-FOR-ITS-COMMERCIAL-DEVELOPMENT,n,6727,EN.jsp" target=_blank>AcCInov, an innovation platform</A></STRONG> that is one of a kind in Europe, will open in September 2013.</STRONG></P> <P align=justify><BR>This project,<STRONG> located at the heart of the <A title="" href="https://www.aderly.com/centre-recherche-et/biotechnology-cluster-lyon,p,21,EN.jsp" target=_blank>Lyon-Gerland biocluster, a facility that brings together a number of leading laboratories in human and animal health</A></STRONG>, marks the second step in Lyonbiop&#244;le&#8217;s infrastructure policy dedicated to covering all of the links in the infectious disease innovation chain. It is an extension of the Infectious Disease Center opened on the Charles M&#233;rieux campus in 2009. </P> <P align=justify><BR><STRONG>AcCInov is the first bioproduction platform serving biotech SMEs at Lyon-Gerland</STRONG>. It offers a range of high-value-added services, including bioproduction units and ready-to-use laboratories, for biotech companies developing breakthrough technologies and innovative therapeutic products. AcCInov aims to speed up the development of its member companies by ensuring quick startup of their activities. </P> <P align=justify>&nbsp;</P> <P align=justify><STRONG>The new 6,000 sq. m. building will triple the surface area dedicated to hosting its members&#8217; <A title="" href="https://www.aderly.com/pharmaceutique_biotech/index,p,100044,EN.jsp" target=_blank>pre-clinical and clinical biotech and biopharma research projects</A></STRONG>. It will be composed of three areas: 1,190 sq. m. of technical platforms for bioproduction (cell lines, recombinant proteins, monoclonal antibodies, and more), 20 analytical laboratories covering 2,040 sq. m. and another 2,040 sq. m. of platforms and technical facilities.<BR></P>